Cormorant Asset Management’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,250,000
| Closed | -$28.6M | – | 63 |
|
|
2024
Q1 | $28.6M | Buy |
+1,250,000
| New | +$28.6M | 1.26% | 26 |
|
|
2023
Q2 | – | Sell |
-90,065
| Closed | -$1.69M | – | 73 |
|
|
2023
Q1 | $1.69M | Hold |
90,065
| – | – | 0.11% | 61 |
|
|
2022
Q4 | $919K | Hold |
90,065
| – | – | 0.06% | 65 |
|
|
2022
Q3 | $2.37M | Sell |
90,065
-27,407
| -23% | -$721K | 0.17% | 57 |
|
|
2022
Q2 | $5.3M | Hold |
117,472
| – | – | 0.4% | 52 |
|
|
2022
Q1 | $11.6M | Sell |
117,472
-783
| -0.7% | -$77K | 0.89% | 33 |
|
|
2021
Q4 | $18.1M | Sell |
118,255
-3,330
| -3% | -$509K | 1.08% | 27 |
|
|
2021
Q3 | $16.3M | Hold |
121,585
| – | – | 0.66% | 40 |
|
|
2021
Q2 | $17.3M | Buy |
+121,585
| New | +$17.3M | 0.59% | 43 |
|